共 141 条
[1]
Sierra del Rio M(2009)Primary CNS lymphoma in immunocompetent patients Oncologist 14 526-539
[2]
Rousseau A(2008)Primary lymphoma of the central nervous system: epidemiology, pathology and current approaches to diagnosis, prognosis and treatment Leuk Lymphoma 49 43-51
[3]
Soussain C(1997)Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: results of a critical review of the literature Ann Oncol 8 227-234
[4]
Ricard D(2008)Primary central nervous system lymphoma Arch Pathol Lab Med 132 1830-1834
[5]
Hoang-Xuan K(2002)Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging Radiology 223 11-29
[6]
Rubenstein J(2011)Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging Am J Neuroradiol 32 507-514
[7]
Ferreri AJM(2010)Differentiation among glioblastoma multiforme, solitary metastatic tumor, and lymphoma using whole-tumor histogram analysis of the normalized cerebral blood volume in enhancing and perienhancing lesions Am J Neuroradiol 31 1699-1706
[8]
Pittaluga S(2009)Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: added value of unenhanced CT compared with conventional contrast-enhanced MR imaging Radiology 251 467-475
[9]
Reni M(2019)Imaging features (CT, MRI, MRS, and PET/CT) of primary central nervous system lymphoma in immunocompetent patients Neurol Sci 40 535-542
[10]
Ferreri AJM(2011)Does adding FDG-PET to MRI improve the differentiation between primary cerebral lymphoma and glioblastoma? Observer performance study Ann Nucl Med 25 432-438